| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $11.4M | +15.4% |
| Cost of Revenue | $3.8M | +15.5% |
| Gross Profit | $7.6M | +15.3% |
| R&D Expense | $617K | +10.5% |
| SG&A Expense | $7.9M | +3.0% |
| Operating Income | -$7.9M | -3.0% |
| Pre-tax Income | -$7.5M | +17.1% |
| Income Tax | $15K | +49.3% |
| Net Income | -$7.5M | +17.1% |
| EPS (Basic) | -$13.06 | +10.9% |
| EPS (Diluted) | -$13.06 | +10.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.6M | -6.1% |
| Short-term Investments | $5.9M | — |
| Accounts Receivable | $6K | +33.5% |
| Inventory | $1.4M | +33.5% |
| Current Assets | $11.6M | +117.3% |
| Total Assets | $20.3M | +42.8% |
| Current Liabilities | $1.9M | -4.8% |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.1M | -18.9% |
| Capital Expenditures | $71K | +178.7% |
| Investing Cash Flow | -$7.3M | -399.8% |
| Financing Cash Flow | $12.1M | +288.0% |
| Free Cash Flow | -$5.1M | -19.9% |
| $2.2M |
| +9.2% |
| Stockholders' Equity | $16.3M | +56.8% |